ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
February 24, 2010  |  By ENCOD In 2010

CONCLUSION OF THE PUBLIC HEARING ON EU DRUG POLICY

2088182_DSC05456.jpg

CONCLUSION OF THE PUBLIC HEARING ON EU DRUG POLICY

23 February 2010

European Parliament, Brussels


2088182_DSC05456.jpg

The hearing was attended by 40 civil society representatives from 15 EU countries

On 23 February 2010, a Public Hearing took place in the European Parliament on the issue of Drug Policy in the European Union. Upon the invitation of Greek MEP Michail Tremopoulos and ENCOD (European Coalition for Just and Effective Drug Policies), approximately 40 representatives of European civil society organisations from 15 different countries came together to formulate their recommendations to Members of the European Parliament, the European Commission and the European Council on the future approach that the European Union should take regarding criminalised drugs. The hearing was attended by representatives of the Drugs Coordination Unit of the European Commission and MEPs Dennis de Jong (Netherlands, GUE) and Michail Tremopoulos (Greece, GREENS).

The hearing was held two weeks before the annual meeting of the United Nations Committee on Narcotic Drugs in Vienna.

The main issue on the agenda of the public hearing was the “Report on Global Illicit Drugs Markets 1998 – 2007” that was financed by the European Commission in 2008. This study was carried out by a team of respected drug researchers chaired by Prof. Peter Reuter of Rand Corporation, USA and Mr. Franz Trautmann of the Trimbos Institute, Netherlands. It came about after many years in which many civil society organisations had called for an independent evaluation of the impact of worldwide drug prohibition.

The report was presented by the Drugs Coordination Unit of the European Commission. Its conclusions prove the theory of drug prohibition – as a tool to reduce production, distribution and consumption of “controlled” drugs – to be false. According to the report, control efforts have minimal effects on the global illegal drugs market, the annual value of which is estimated at 300 billion US dollars.

2459730_DSC05490.jpg

Carel Edwards (European Commission), Michail Tremopoulos (MEP), Fredrick Polak (ENCOD) and George Oikonomopoulos ( Elefsyna, Greece)

Production controls have some local successes but are unable to affect the availability of drugs globally; trafficking controls are no more successful.

Treatment reduces harms both of dependent users and of society without reducing the prevalence of drug use.

Prevention efforts are handicapped by the lack of programs of proven efficacy.

Harm reduction has helped an increasing number of countries but is focused on a narrow element of the drug problem.

Enforcement fails to prevent continued availability at lower price. Likewise it has caused substantial harms, unevenly distributed across countries. Drug prohibition is a major cause of violence, corruption, environmental and health damage. These problems are responsible for the death, disease and serious deterioration of life standards of millions of people, consumers, their surroundings and society at large.

2744291_DSC05570.jpg

Dennis de Jong (MEP)

In short, the conclusion of the report is that drug policy based on prohibition has done enormous harm and little, if any, good. The European Union should be congratulated for having provided the research to establish this conclusion. Now, it should act upon this knowledge. Ignoring it would be equal to criminal negligence.

Therefore the Public Hearing calls upon European Union institutions to take the following initiatives.

1. To organize as soon as possible a European summit on the future of drug policies, to which national and local authorities, parliamentarians and civil society representatives from the 27 Member States should be invited. The goal of the summit should be to explore the margins to apply innovative drug policies not based on prohibition, but based on the lessons of the Reuter Trautmann report and on the experiences of local authorities and civil society organizations.

2. To issue a general recommendation to Member States to make a review of their drug policies a political priority. The EU should allow each country to choose the drug policies it considers adequate, within a context of respect for human rights, individual freedom and social cohesion, and which cause the least collateral damage possible.

2951492_DSC05615.jpg

Bruno Valkeneers (Liaison Antiprohibitioniste, Bruxelles)

3. To use the opportunity of the coming meeting of the Commission on Narcotic Drugs of the United Nations in Vienna, to emphasize the importance of harm reduction and launch a debate on a review of the UN Conventions, in order to facilitate alternative ways to regulate the drugs market that are not based on prohibition.

4. To explore ways to increase the margin of tolerance towards initiatives taken by European Union citizens to create closed circuits for the production and distribution of an amount of cannabis that is necessary for their personal consumption, as an effort to reduce harm and dependence on the black market.

3122297_DSC05642.jpg

Carel Edwards, Head of the Drugs Coordination Unit of the European Commission

2088182_DSC05456.jpg
2459730_DSC05490.jpg
2744291_DSC05570.jpg
2951492_DSC05615.jpg
3122297_DSC05642.jpg
Previous Story75 ANOS, PRESA POR CULTIVAR CANNABIS
Next StorySPEECH JOEP OOMEN AT THE PUBLIC HEARING ON EU DRUG POLICY

Related Articles

  • arton2767
    QUESTIONS TO THE EUROPEAN COMMISSION
  • arton2669
    MEETING CORE GROUP FOR CIVIL SOCIETY FORUM

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
CONCLUSION OF THE PUBLIC HEARING ON EU DRUG POLICY